Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. A vaccine targeted specifically to prevent cerebral malaria - is there hope?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The GMZ2 malaria vaccine: from concept to efficacy in humans

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Pre-clinical and clinical development of the first placental malaria vaccine

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Heart failure associated with imported malaria: a nationwide Danish cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Precipitated Malaria: It Never Rains but It Pours

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Vaccines are very cost-effective tools in combating infectious disease mortality and morbidity. Unfortunately, vaccines efficiently protecting against infection with malaria parasites are not available and are not likely to appear in the near future. An alternative strategy would be vaccines protecting against the disease and its consequences rather than against infection per se, by accelerating the development of the protective immunity that is normally acquired after years of exposure to malaria parasites in areas of stable transmission. This latter strategy is being energetically pursued to develop a vaccine protecting pregnant women and their offspring against mortality and morbidity caused by the accumulation of Plasmodium falciparum-infected erythrocytes in the placenta. It is based on a detailed understanding of the parasite antigen and the host receptor involved in this accumulation, as well as knowledge regarding the protective immune response that is acquired in response to placental P. falciparum infection. Nevertheless, it remains controversial in some quarters whether such a vaccine would have the desired impact, or indeed whether the strategy is meaningful. This article critically examines the relevance of several perceived obstacles to development of a vaccine against placental malaria.
OriginalsprogEngelsk
TidsskriftExpert Review of Vaccines
Vol/bind10
Udgave nummer10
Sider (fra-til)1405-14
Antal sider10
ISSN1476-0584
DOI
StatusUdgivet - 1 okt. 2011

ID: 32768977